View in EDS

Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy.

Saved in:
Bibliographic Details
Title: Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy.
Authors: Kelly PN; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892., Romero DL; Nimbus Therapeutics, Cambridge, MA 02141., Yang Y; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892., Shaffer AL 3rd; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892., Chaudhary D; Nimbus Therapeutics, Cambridge, MA 02141., Robinson S; Schrödinger, New York, NY 10036., Miao W; Nimbus Therapeutics, Cambridge, MA 02141., Rui L; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892., Westlin WF; Nimbus Therapeutics, Cambridge, MA 02141., Kapeller R; Nimbus Therapeutics, Cambridge, MA 02141., Staudt LM; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 lstaudt@mail.nih.gov.
Source: The Journal of experimental medicine [J Exp Med] 2015 Dec 14; Vol. 212 (13), pp. 2189-201. Date of Electronic Publication: 2015 Nov 30.
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-9538
DOI:10.1084/jem.20151074